부산대학교 도서관

Guo, S.; Lahav, A.; Zhou, Q.; Boulenc, P.; Klekachev, A.V.; Zhuang, X.; Wang, X.

IEEE Electron Device Letters IEEE Electron Device Lett. Electron Device Letters, IEEE. 46(6):940-943 Jun, 2025

Sordello S; Translational Biology, Infection Diseases, Evotec France, Toulouse, France.; Brock L; Translational Biology, Infection Diseases, Evotec France, Toulouse, France.; Tagliavini A; Pharmacometrics, Aptuit (an Evotec Company), Verona, Italy.; Federico D; Pharmacometrics, Aptuit (an Evotec Company), Verona, Italy.; Boulenc X; DMPK, Evotec Infectious Diseases Lyon, Lyon, France.; Pergher M; Pharmacometrics, Aptuit (an Evotec Company), Verona, Italy.; Huc Claustre E; Translational Biology, Infection Diseases, Evotec France, Toulouse, France.; Metcalf D; DMPK, Evotec France, Toulouse, France.; Walter ND; Rocky Mountain Regional VA Medical Center, Aurora, Colorado, USA.; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Consortium for Applied Microbial Metrics, Aurora, Colorado, USA.; Robertson GT; Consortium for Applied Microbial Metrics, Aurora, Colorado, USA.; Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA.; Clary J; Allucent (US) LLC, Cary, North Carolina, USA.; Berg A; Allucent (US) LLC, Cary, North Carolina, USA.; IceBerg Consulting, West Fargo, North Dakota, USA.; Mdluli K; Gates Medical Research Institute, Cambridge, Massachusetts, USA.; Hermann D; Gates Foundation, Seattle, Washington, USA.; Flood D; Gates Foundation, Seattle, Washington, USA.; Upton AM; Evotec USA inc., New Jersey, USA.

Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

Van Sieleghem, Edward; Süss, Andreas; Boulenc, Pierre; Lee, Jiwon; Karve, Gauri; De Munck, Koen; Cavaco, Celso; Van Hoof, Chris

Maillard, L; Hamon, M; Khalife, K; Steg, PG; Beygui, F; Guermonprez, JL; Spaulding, CM; Boulenc, JP; Lipiecki, J; Lafont, A; Brunel, P; Grollier, G; Koning, R; Coste, P; Favereau, X; Lancelin, B; van Belle, E; Serruys, PWJC (Patrick); Monassier, JP; Raynaud, P

Journal of the American College of Cardiology. 35:1729-1736

M C, Grès; B, Julian; M, Bourrié; V, Meunier; C, Roques; M, Berger; X, Boulenc; Y, Berger; G, Fabre

Pharmaceutical Research. 15:726-733

D, Dussossoy; M L, Py; G, Pastor; X, Boulenc

Journal of Pharmaceutical Sciences. 85:955-959

X, Boulenc; E, Marti; H, Joyeux; C, Roques; Y, Berger; G, Fabre

Biochemical Pharmacology. 46:1591-1600

X, Boulenc; M, Bourrie; I, Fabre; C, Roque; H, Joyeux; Y, Berger; G, Fabre

The Journal of Pharmacology and Experimental Therapeutics. 263:1471-1478

I, Dalet-Beluche; X, Boulenc; G, Fabre; P, Maurel; C, Bonfils

European Journal of Biochemistry. 204:641-648

Murithi JM; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.; Pascal C; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Bath J; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.; Boulenc X; Sanofi Pasteur, Marcy L'Etoile, France.; Gnädig NF; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.; Pasaje CFA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Rubiano K; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.; Yeo T; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.; Mok S; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.; Klieber S; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France.; Desert P; Sanofi Pasteur, Marcy L'Etoile, France.; Jiménez-Díaz MB; The Art of Discovery, Bizkaia, Basque Country, Spain.; Marfurt J; Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.; Rouillier M; Medicines for Malaria Venture, Geneva, Switzerland.; Cherkaoui-Rbati MH; Medicines for Malaria Venture, Geneva, Switzerland.; Gobeau N; Medicines for Malaria Venture, Geneva, Switzerland.; Wittlin S; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; Universität Basel, Basel, Switzerland.; Uhlemann AC; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.; Price RN; Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.; Wirjanata G; Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.; Noviyanti R; Eijkman Institute for Molecular Biology, Jakarta, Indonesia.; Tumwebaze P; Infectious Diseases Research Collaboration, Kampala, Uganda.; Cooper RA; Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, CA, USA.; Rosenthal PJ; Department of Medicine, University of California, San Francisco, CA, USA.; Sanz LM; Global Health Pharma Research Unit, GSK, Tres Cantos, Madrid, Spain.; Gamo FJ; Global Health Pharma Research Unit, GSK, Tres Cantos, Madrid, Spain.; Joseph J; Syngene International Ltd., Bangalore, India.; Singh S; Syngene International Ltd., Bangalore, India.; Bashyam S; Syngene International Ltd., Bangalore, India.; Augereau JM; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Giraud E; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Bozec T; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Vermat T; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Tuffal G; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France.; Guillon JM; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Menegotto J; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Sallé L; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France.; Louit G; Sanofi, Vitry-sur-Seine, France.; Cabanis MJ; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France.; Nicolas MF; Sanofi, Vitry-sur-Seine, France.; Doubovetzky M; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Merino R; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Bessila N; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Angulo-Barturen I; The Art of Discovery, Bizkaia, Basque Country, Spain.; Baud D; Medicines for Malaria Venture, Geneva, Switzerland.; Bebrevska L; Medicines for Malaria Venture, Geneva, Switzerland.; Escudié F; Medicines for Malaria Venture, Geneva, Switzerland.; Niles JC; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Blasco B; Medicines for Malaria Venture, Geneva, Switzerland.; Campbell S; Medicines for Malaria Venture, Geneva, Switzerland.; Courtemanche G; Bioaster, Paris, France.; Fraisse L; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Pellet A; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France.; Fidock DA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA. df2260@cumc.columbia.edu leroyd@mmv.org.; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.; Leroy D; Medicines for Malaria Venture, Geneva, Switzerland. df2260@cumc.columbia.edu leroyd@mmv.org.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Renard S; Evotec, 40 Avenue Tony Garnier, Lyon 69007, France.; Versluys S; Evotec, 195, Route d'Espagne, Toulouse 31100, France.; Taillier T; Evotec, 1541, Avenue Marcel Mérieux, Marcy L'Etoile 69280, France.; Dubarry N; Evotec, 40 Avenue Tony Garnier, Lyon 69007, France.; Leroi-Geissler C; Evotec, 40 Avenue Tony Garnier, Lyon 69007, France.; Rey A; Evotec, 1541, Avenue Marcel Mérieux, Marcy L'Etoile 69280, France.; Cornaire E; Evotec, 1541, Avenue Marcel Mérieux, Marcy L'Etoile 69280, France.; Sordello S; Evotec, 195, Route d'Espagne, Toulouse 31100, France.; Carry JB; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Angouillant-Boniface O; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Gouyon T; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Thompson F; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Lebourg G; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Certal V; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Balazs L; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Arranz E; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Doerflinger G; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Bretin F; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Gervat V; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Brohan E; Sanofi, 13 Quai Jules Guesde, Vitry-sur-Seine 94403, France.; Kraft V; Sanofi-Aventis Deutschland GmbH, Industriepark Hoechst, Frankfurt am Main 65926, Germany.; Boulenc X; Evotec, 40 Avenue Tony Garnier, Lyon 69007, France.; Ducelier C; Sanofi, 1 Avenue Pierre Brossolette, Chilly-Mazarin 91385, France.; Bacqué E; Evotec, 1541, Avenue Marcel Mérieux, Marcy L'Etoile 69280, France.; Couturier C; Evotec, 1541, Avenue Marcel Mérieux, Marcy L'Etoile 69280, France.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

Chapy H; Drug Disposition Domain, Disposition Safety and Animal Research, Sanofi, Montpellier, France.; Klieber S; Drug Disposition Domain, Disposition Safety and Animal Research, Sanofi, Montpellier, France.; Brun P; Drug Disposition Domain, Disposition Safety and Animal Research, Sanofi, Montpellier, France.; Gerbal-Chaloin S; INSERM, U1040, Institut de Recherche en Biothérapie, Montpellier, F-34293, France.; Université Montpellier 1, UMR 1040, Montpellier, F-34293, France.; Boulenc X; Drug Disposition Domain, Disposition Safety and Animal Research, Sanofi, Montpellier, France.; Nicolas O; Drug Disposition Domain, Disposition Safety and Animal Research, Sanofi, Montpellier, France.

Publisher: Wiley Country of Publication: England NLM ID: 7911226 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-081X (Electronic) Linking ISSN: 01422782 NLM ISO Abbreviation: Biopharm Drug Dispos Subsets: MEDLINE

Boulenc X; Drug Safety and Animal Research, Drug Disposition Domain, Sanofi Research and Development, Montpellier, France.; Barberan O

Publisher: De Gruyter Country of Publication: Germany NLM ID: 8904736 Publication Model: Print Cited Medium: Print ISSN: 0792-5077 (Print) Linking ISSN: 07925077 NLM ISO Abbreviation: Drug Metabol Drug Interact Subsets: MEDLINE

Ciobotaru, Vlad; Maupas, Eric; Dürrleman, Nicolas; Boulenc, Jean-Marc; Borton, Augustin; Pujadas-Berthault, Pénélope; Rioux, Philippe; Maubon, Antoine

European Heart Journal - Cardiovascular Imaging (EUR HEART J CARDIOVASC IMAGING), Jan2016; 17(1): 85-95. (11p)

Turpault S; Global Metabolism and Pharmacokinetics, Sanofi-Aventis, Malvern, PA, USA. sandrine.turpault@sanofi-aventis.com; Brian W; Van Horn R; Santoni A; Poitiers F; Donazzolo Y; Boulenc X

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

Da-Silva F; Sanofi R&D, Montpellier, France; Institute for Regenerative Medicine and Biotherapy, Université et CHU de Montpellier, INSERM, Montpellier, France.; Boulenc X; Sanofi R&D, Montpellier, France.; Vermet H; Sanofi R&D, Montpellier, France.; Compigne P; Sanofi R&D, Montpellier, France.; Gerbal-Chaloin S; Institute for Regenerative Medicine and Biotherapy, Université et CHU de Montpellier, INSERM, Montpellier, France.; Daujat-Chavanieu M; Institute for Regenerative Medicine and Biotherapy, Université et CHU de Montpellier, INSERM, Montpellier, France.; Klieber S; Sanofi R&D, Montpellier, France. Electronic address: sylvie.klieber@sanofi.com.; Poulin P; Consultant, Patrick Poulin Inc., Québec City, Canada; Associate professor, School of Public Health, IRSPUM, Université de Montréal, Canada.

Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6017 (Electronic) Linking ISSN: 00223549 NLM ISO Abbreviation: J Pharm Sci Subsets: MEDLINE

Margolskee A; University of Manchester, United Kingdom. Electronic address: alison.margolskee@manchester.ac.uk.; Darwich AS; University of Manchester, United Kingdom.; Pepin X; AstraZeneca, United Kingdom; Sanofi, France.; Pathak SM; Simcyp Ltd., United Kingdom.; Bolger MB; Simulations Plus, Inc., United States.; Aarons L; University of Manchester, United Kingdom.; Rostami-Hodjegan A; University of Manchester, United Kingdom; Simcyp Ltd., United Kingdom.; Angstenberger J; AbbVie, Germany.; Graf F; AbbVie, Germany.; Laplanche L; AbbVie, Germany.; Müller T; AbbVie, Germany.; Carlert S; AstraZeneca, Sweden.; Daga P; AstraZeneca, United States.; Murphy D; AstraZeneca, United Kingdom.; Tannergren C; AstraZeneca, Sweden.; Yasin M; AstraZeneca, United Kingdom.; Greschat-Schade S; Bayer Pharma AG, Germany.; Mück W; Bayer Pharma AG, Germany.; Muenster U; Bayer Pharma AG, Germany.; van der Mey D; Bayer Pharma AG, Germany.; Frank KJ; Boehringer Ingelheim Pharma GmbH & Co. KG, Germany.; Lloyd R; GlaxoSmithKline, United Kingdom.; Adriaenssen L; Janssen, Belgium.; Bevernage J; Janssen, Belgium.; De Zwart L; Janssen, Belgium.; Swerts D; Janssen, Belgium.; Tistaert C; Janssen, Belgium.; Van Den Bergh A; Janssen, Belgium.; Van Peer A; Janssen, Belgium.; Beato S; Novartis, Switzerland.; Nguyen-Trung AT; Novartis, Switzerland.; Bennett J; Pfizer, United Kingdom.; McAllister M; Pfizer, United Kingdom.; Wong M; Pfizer, United Kingdom.; Zane P; Sanofi, United States.; Ollier C; Sanofi, France.; Vicat P; Sanofi, France.; Kolhmann M; Sanofi, Germany.; Marker A; Sanofi, Germany.; Brun P; Sanofi, France.; Mazuir F; Sanofi, France.; Beilles S; Sanofi, France.; Venczel M; Sanofi, Germany.; Boulenc X; Sanofi, France.; Loos P; Sanofi, Germany.; Lennernäs H; Uppsala University, Sweden.; Abrahamsson B; AstraZeneca, Sweden.

Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE

Boulenc X; Drug Disposition Domain, Disposition Safety and Animal Research, Sanofi, 371 rue du Professeur J. Blayac, 34184, Montpellier Cedex 04, France. xavier.boulenc@sanofi.com.; Nicolas O; Drug Disposition Domain, Disposition Safety and Animal Research, Sanofi, 371 rue du Professeur J. Blayac, 34184, Montpellier Cedex 04, France.; Hermabessière S; Clinical and Exploratory Pharmacology, Sanofi, Montpellier, France.; Zobouyan I; Clinical Documentation, Sanofi, Montpellier, France.; Martin V; Biostatistics, Sanofi, Chilly-Mazarin, France.; Donazzolo Y; Eurofins Optimed, Lyon, France.; Ollier C; Drug Disposition Domain, Disposition Safety and Animal Research, Sanofi, 371 rue du Professeur J. Blayac, 34184, Montpellier Cedex 04, France.

Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2107-0180 (Electronic) Linking ISSN: 03787966 NLM ISO Abbreviation: Eur J Drug Metab Pharmacokinet Subsets: MEDLINE

Vermet H; Drug Disposition Domain, Disposition, Safety and Animal Research Scientific Core Platform (H.V., N.R., R.N., S.K., G.F., X.B.); Biostatistics and Programming, Clinical Sciences & Operations, Scientific Core Platform (L.E.), Sanofi Recherche & Développement, Montpellier, France.; Raoust N; Drug Disposition Domain, Disposition, Safety and Animal Research Scientific Core Platform (H.V., N.R., R.N., S.K., G.F., X.B.); Biostatistics and Programming, Clinical Sciences & Operations, Scientific Core Platform (L.E.), Sanofi Recherche & Développement, Montpellier, France.; Ngo R; Drug Disposition Domain, Disposition, Safety and Animal Research Scientific Core Platform (H.V., N.R., R.N., S.K., G.F., X.B.); Biostatistics and Programming, Clinical Sciences & Operations, Scientific Core Platform (L.E.), Sanofi Recherche & Développement, Montpellier, France.; Esserméant L; Drug Disposition Domain, Disposition, Safety and Animal Research Scientific Core Platform (H.V., N.R., R.N., S.K., G.F., X.B.); Biostatistics and Programming, Clinical Sciences & Operations, Scientific Core Platform (L.E.), Sanofi Recherche & Développement, Montpellier, France.; Klieber S; Drug Disposition Domain, Disposition, Safety and Animal Research Scientific Core Platform (H.V., N.R., R.N., S.K., G.F., X.B.); Biostatistics and Programming, Clinical Sciences & Operations, Scientific Core Platform (L.E.), Sanofi Recherche & Développement, Montpellier, France.; Fabre G; Drug Disposition Domain, Disposition, Safety and Animal Research Scientific Core Platform (H.V., N.R., R.N., S.K., G.F., X.B.); Biostatistics and Programming, Clinical Sciences & Operations, Scientific Core Platform (L.E.), Sanofi Recherche & Développement, Montpellier, France.; Boulenc X; Drug Disposition Domain, Disposition, Safety and Animal Research Scientific Core Platform (H.V., N.R., R.N., S.K., G.F., X.B.); Biostatistics and Programming, Clinical Sciences & Operations, Scientific Core Platform (L.E.), Sanofi Recherche & Développement, Montpellier, France xavier.boulenc@sanofi.com.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE

Djebli N; Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France nassim.djebli@sanofi.com.; Fabre D; Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France.; Boulenc X; Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France.; Fabre G; Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France.; Sultan E; Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France.; Hurbin F; Sanofi R&D, Drug Disposition, Disposition Safety and Animal Research, Montpellier, France.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE